Overview
This highly interactive three-day program will provide a comprehensive review of the data on the most important aspects of breast cancer biology, diagnostics, prevention, and treatment and will include lectures and panel discussions with leading clinical investigators that emphasize how best to incorporate the information into clinical practice.
Learning Objectives
Upon completion of this activity, learners will be better able to:
- Integrate tumor subtype, genomic and molecular biomarkers, and results from gene expression assays into personalized treatment plans to optimize outcomes for patients with breast cancer
- Incorporate best practices and emerging evidence regarding diagnosis, monitoring, and locoregional management of patients with breast cancer
- Assess the potential impact of the latest findings from key clinical trials across early-stage and metastatic breast cancers on evolving treatment paradigms
- Develop individualized, evidence-informed treatment plans for patients with breast cancer based on the latest research findings and expert clinical recommendations
- Implement supportive care strategies for preventing, mitigating, and managing treatment-related adverse events in patients receiving novel therapies for breast cancer
Target Audience
This educational program is directed toward medical, radiation, and surgical oncologists whose primary practice focus is breast cancer and who desire to increase their knowledge and expand their expertise in breast cancer diagnosis, treatment, and management. Participants will be primarily oncologists or fellows in training whose practice requires mastery and a critical understanding of the fundamental principles, pivotal published studies, and emerging information on the pathogenesis and management of breast cancer.
Joyce O’Shaughnessy, MD
Celebrating Women Chair in Breast Cancer Research
Baylor University Medical Center
Director, Breast Cancer Research Program
Texas Oncology
The US Oncology Network
Dallas, TX
Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC, designates this live activity for a maximum of 27.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 27.50 Contact Hours (Day 1=10; Day 2=9.75; Day 3=7.75).
Medical Oncologists (ABIM)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 27.50 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
There are several opportunities (both continuing education [CE] and non-CE) available for companies, associations, and societies interested in supporting this year's conference.
For Continuing Education, Associations, and Societies
Please email grants@gotoper.com for information about this upcoming conference.
Exhibitors
Exhibit at this year’s meeting and increase your visibility. Our custom sponsorship packages provide outstanding recognition and increased awareness of your company’s products and services. Don’t miss this opportunity to reach this important target audience.
For additional details, contact:
Elisha Ball | Associate Director of Sales
OncLive® Events & Intellisphere Oncology Specialty Group
Cell: (610) 563-1620
Email: egarcia@onclive.com
Maddison Martini | National Accounts Associate
OncLive® Events & Intellisphere Oncology Specialty Group
Cell: (609) 947-8377
Email: mmartini@mjhlifesciences.com
OncLive® Events & Intellisphere Oncology Specialty Group
259 Prospect Plains Rd, Building H, Monroe, NJ 08831
Web: http://www.onclive.com
Advisory Board or Ancillary Meeting Definition
Any meeting whose invited participants are professional attendees of the Conference, such as doctors and physicians will be considered an Advisory Board (Ad Board) or Ancillary Meeting. This includes activities such as round-table discussions, investigator meetings, social gatherings and meet the specialist‐type meetings.
A fee is applicable for hosting these meetings, with the amount being dependent on the type and size of your meeting.
Blackout Times
There are many programs being scheduled throughout our conferences. With that, the black out hours across our meeting are as follows:
- One day prior to the conferences
- The duration of the conference
- One day post conference
To review your meeting request, please contact Elisha Ball or Maddison Martini.
A cancellation fee of 25% will be assessed on refunds requested 90 days before the start date, a 50% fee on refunds requested 60 days before the start date, and a 75% fee on refunds requested 30 days before the start date. No refunds will be made after 30 days before the start date. There is no charge for substitution. Substitutions can only be applied to the same conference and only two substitutions will be honored.
In the event of a meeting cancellation, full refunds will be processed within 30 days of the cancellation date.
PER® reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited. This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting continuing education materials.